Viveon Health Acquisition Corp. (VHAQ)

NYSEAMERICAN: VHAQ · IEX Real-Time Price · USD
10.36
+0.01 (0.10%)
Sep 28, 2022 4:00 PM EDT - Market closed
0.10%
Market Cap 104.26M
Revenue (ttm) n/a
Net Income (ttm) -263,256
Shares Out 10.06M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,201
Open 10.34
Previous Close 10.35
Day's Range 10.34 - 10.36
52-Week Range 9.95 - 10.45
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About VHAQ

Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia. [Read more...]

Industry Blank Check / SPAC
IPO Date Dec 23, 2020
Country United States
Stock Exchange NYSEAMERICAN
Ticker Symbol VHAQ
Full Company Profile

Financial Performance

Financial Statements

News

Suneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP Treatments

SAN DIEGO , Sept. 13, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative products to change the standard of care in patien...

2 weeks ago - PRNewsWire

Viveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with its Propose...

SAN DIEGO & NORCROSS, Ga.--(BUSINESS WIRE)--Viveon Health Acquisition Corp. (NYSE: VHAQ) (“Viveon Health” or “VHAQ”), a special purpose acquisition company, and Suneva Medical, Inc. (“Suneva” or the “Co...

2 months ago - Business Wire

Viveon Health Acquisition Corp. Receives Noncompliance Notice Regarding Late Form 10-Q Filing From the NYSE

NEW YORK--(BUSINESS WIRE)--Viveon Health Acquisition Corp. (NYSE: “VHAQU” or the “Company”) announces that on May 24, 2022, as a result of its inability to timely file with the Securities and Exchange C...

4 months ago - Business Wire

Suneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and Canada

Canadian Regulators have approved Dermapose®  All-In-One fat sizing syringe U.S. FDA 510(k) clearance for a larger volume Amplifine PRP Gel Tube SAN DIEGO , May 3, 2022 /PRNewswire/ -- Suneva Medical, I...

4 months ago - PRNewsWire

Viveon Health Acquisition Corp. Received Audit Opinion with Going Concern Explanation

NEW YORK--(BUSINESS WIRE)--Viveon Health Acquisition Corp. ("Viveon" or the "Company") (NYSE American: VHAQ) today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ...

5 months ago - Business Wire

Viveon Health Acquisition Corp. Announces Board and Stockholder Approval to Extend Period to Consummate Business Comb...

NORCROSS, Ga. , March 21, 2022 /PRNewswire/ -- Viveon Health Acquisition Corp. (NYSE American: VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced the approval of its boa...

6 months ago - PRNewsWire

Viveon Health Acquisition Corp. Announces Clarified Contribution Terms in Connection with the Extension Related to Me...

NORCROSS, Ga. , Feb. 11, 2022 /PRNewswire/ -- Viveon Health Acquisition Corp. (NYSE American: VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, today announced that it is clarify...

7 months ago - PRNewsWire

Suneva Surpasses 1 Million Syringes of Bellafill® Distributed Since the Biostimulator's Inception

SAN DIEGO, Feb. 8, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic...

7 months ago - PRNewsWire

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Viveon Health Acquisition Corp. Merger

Wilmington, Delaware--(Newsfile Corp. - February 4, 2022) - Rigrodsky Law, P.A. announces that it is investigating Viveon Health Acquisition Corp. ("Viveon") (NYSE American: VHAQ) regarding possible bre...

7 months ago - Newsfile Corp

FDA Accepts Label Update for Plasma IQ™, the First FDA-Cleared Handheld Plasma Energy Device

SAN DIEGO, Jan. 28, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aestheti...

8 months ago - PRNewsWire

Regenerative Aesthetics Firm Suneva Medical Gets SPAC Support To Go Public

Suneva Medical Inc, medical aesthetics player, will soon form a reverse merger with Viveon Health Acquisition Corp (NYSE: VHAQ), a special purpose acquisition company. Viveon Health went public through ...

8 months ago - Benzinga

Suneva Medical Inc. and Viveon Health Acquisition Corp. Announce Merger Agreement to Create a Leading Regenerative Ae...

SAN DIEGO and  NORCROSS, Ga., Jan. 12, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard ...

8 months ago - PRNewsWire

Viveon Health Acquisition Corp. Announces the Separate Trading of its Common Stock, Warrants and Rights Commencing Fe...

New York, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (the “Company” or “Viveon Health”) (NYSE American: VHAQU) announced that, commencing February 4, 2021, holders of the units so...

1 year ago - GlobeNewsWire

Viveon Health Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering

NEW YORK, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: VHAQU) today announced the underwriters of its previously announced public offering of units have exercised their over-...

1 year ago - GlobeNewsWire

Viveon Health Acquisition Corp. Announces Closing of $175 Million Initial Public Offering

New York, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: “VHAQU” or the “Company”) announced today that it closed its initial public offering of 17,500,000 units, resulting in ...

1 year ago - GlobeNewsWire

Viveon Health Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering

New York, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (the “Company” or “Viveon Health”) announced today that it priced its initial public offering of 17,500,000 units at $10.00 pe...

1 year ago - GlobeNewsWire